In the present study, we provide evidence that high serum IFN-γ levels, before or after MSCT, are positively associated with a reduced DAS28 value in RA patients and may be used as a biomarker to predict the clinical efficacy of or select RA patients for allogeneic MSCT. Here, IFNG is linked to rheumatoid arthritis.